Hangzhou Minsheng Healthcare Co Ltd (301507) - Total Assets
Based on the latest financial reports, Hangzhou Minsheng Healthcare Co Ltd (301507) holds total assets worth CN¥1.97 Billion CNY (≈ $288.64 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Hangzhou Minsheng Healthcare Co Ltd (301507) shareholders funds for net asset value and shareholders' equity analysis.
Hangzhou Minsheng Healthcare Co Ltd - Total Assets Trend (2021–2024)
This chart illustrates how Hangzhou Minsheng Healthcare Co Ltd's total assets have evolved over time, based on quarterly financial data.
Hangzhou Minsheng Healthcare Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Hangzhou Minsheng Healthcare Co Ltd's total assets of CN¥1.97 Billion consist of 72.1% current assets and 27.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 19.4% |
| Accounts Receivable | CN¥46.99 Million | 2.7% |
| Inventory | CN¥105.55 Million | 6.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥35.26 Million | 2.0% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Hangzhou Minsheng Healthcare Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Hangzhou Minsheng Healthcare Co Ltd market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hangzhou Minsheng Healthcare Co Ltd's current assets represent 72.1% of total assets in 2024, an increase from 60.7% in 2021.
- Cash Position: Cash and equivalents constituted 19.4% of total assets in 2024, up from 3.3% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 5.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 6.1% of total assets.
Hangzhou Minsheng Healthcare Co Ltd Competitors by Total Assets
Key competitors of Hangzhou Minsheng Healthcare Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
AbbVie Inc
NYSE:ABBV
|
USA | $133.96 Billion |
|
Roche Holding AG
SW:ROG
|
Switzerland | CHF100.70 Billion |
|
Biogen Inc
NASDAQ:BIIB
|
USA | $29.44 Billion |
|
CSPC Pharmaceutical Group Limited
F:CVG
|
Germany | €46.00 Billion |
|
AstraZeneca PLC
LSE:AZN
|
UK | GBX114.07 Billion |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019
|
China | CN¥13.11 Billion |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
|
China | CN¥2.58 Billion |
|
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3
|
Brazil | R$3.83 Billion |
Hangzhou Minsheng Healthcare Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.97 | 6.73 | 6.73 |
| Quick Ratio | 4.73 | 6.36 | 6.36 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.09 Billion | CN¥1.07 Billion | CN¥1.07 Billion |
Hangzhou Minsheng Healthcare Co Ltd - Advanced Valuation Insights
This section examines the relationship between Hangzhou Minsheng Healthcare Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.41 |
| Latest Market Cap to Assets Ratio | 0.44 |
| Asset Growth Rate (YoY) | 5.9% |
| Total Assets | CN¥1.74 Billion |
| Market Capitalization | $770.10 Million USD |
Valuation Analysis
Below Book Valuation: The market values Hangzhou Minsheng Healthcare Co Ltd's assets below their book value (0.44x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Hangzhou Minsheng Healthcare Co Ltd's assets grew by 5.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Hangzhou Minsheng Healthcare Co Ltd (2021–2024)
The table below shows the annual total assets of Hangzhou Minsheng Healthcare Co Ltd from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.74 Billion ≈ $255.29 Million |
+5.87% |
| 2023-12-31 | CN¥1.65 Billion ≈ $241.13 Million |
+115.32% |
| 2022-12-31 | CN¥765.29 Million ≈ $111.99 Million |
+12.30% |
| 2021-12-31 | CN¥681.49 Million ≈ $99.72 Million |
-- |
About Hangzhou Minsheng Healthcare Co Ltd
Hangzhou Minsheng Healthcare Co., Ltd. engages in the research, development, production, and sale of vitamins and mineral supplements, OTC drugs, and health foods in China. The company offers healthy products, such as fish and algae oil gel candy, collagen peptide vitamin D calcium chewable tablets, blueberry lutein ester candy tablets, and probiotic solid beverage. It also provides multivitamin,… Read more